Abbott Laboratories and Deltanoid Pharmaceuticals Inc., a privately held company based in Madison, Wis, today announced the completion of an option and license agreement to develop novel Vitamin D Receptor Activators (VDRAs) for the treatment of renal disease.
Office of Strategic Communication